Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - StemCells, Inc. (NasdaqNM:STEM)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Msgs | Insider | Financials
Recent Events
Aug 13Earnings Announcement
Location
3155 Porter Drive
Palo Alto, CA 94304
Phone: (650) 475-3100
Email: offadm@stemcell.net
Employees (last reported count): 26
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Related Links
 ·Search Yahoo! for related links...
Ownership
·Insider and 5%+ Owners: 14%
·Institutional: 5% (6% of float)
(27 institutions)
·Net Inst. Selling: 151.0K shares (+13.60%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
StemCells, Inc. is a biopharmaceutical company that is engaged in the development of novel stem cell therapies designed to treat and possibly cure, human diseases and disorders such as Parkinson's disease, hepatitis, diabetes and spinal cord injuries. The Company's proposed therapies are based on the transplanting of healthy human stem and progenitor cells to repair or replace central nervous system, pancreas or liver tissue that has been damaged or lost as a result of disease or injury. The Company has established an intellectual property position in all three areas of its stem cell research, the central nervous system, the pancreas and the liver, by patenting its discoveries and entering into exclusive licensing arrangements.
More from Market Guide: Expanded Business Description

Financial Summary
StemCells, Inc. is a biotechnology company focused on the discovery, development and commercialization of stem cell-based therapies to treat diseases of the central nervous system, liver and pancreas. For the six months ended 6/30/01, revenues totalled $400 thousand, up from none. Net income applicable to Common totalled $1.9 million, vs. a loss of $2.6 million. Results reflect initial revenues as well as a $7.8 million gain on the sale of the Company's investment in Modex.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

John Schwartz, Ph.D., 67
Chairman
--  
Martin McGlynn, 54
Pres, CEO, Director
--  
Ronnda Bartel, Ph.D., 42
VP, Scientific Devel.
$133K
Ann Tsukamoto, Ph.D., 48
VP, Scientific Operations
164K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:STEMAs of 31-Aug-2001
Price and Volume
52-Week Low
on 5-Apr-2001
$1.469
Recent Price$3.10 
52-Week High
on 1-Sep-2000
$9.50 
Beta0.39 
Daily Volume (3-month avg)889.5K
Daily Volume (10-day avg)306.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-65.3%
52-Week Change
relative to S&P500
-53.5%
Share-Related Items
Market Capitalization$71.6M
Shares Outstanding23.1M
Float19.9M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.45 
Earnings (ttm)-$0.34 
Earnings (mrq)$0.07 
Sales (ttm)$0.02 
Cash (mrq)$0.43 
Valuation Ratios
Price/Book (mrq)6.97 
Price/EarningsN/A 
Price/Sales (ttm)142.66 
Income Statements
Sales (ttm)$474.0K
EBITDA (ttm)-$12.4M
Income available to common (ttm)-$6.94M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-24.29%
Return on Equity (ttm)-32.43%
Financial Strength
Current Ratio (mrq)3.68 
Debt/Equity (mrq)0.25 
Total Cash (mrq)$9.44M
Short Interest
As of 8-Aug-2001
Shares Short1.82M
Percent of Float9.1%
Shares Short
(Prior Month)
1.07M
Short Ratio1.20 
Daily Volume1.51M
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.